JP2000504328A5 - - Google Patents

Download PDF

Info

Publication number
JP2000504328A5
JP2000504328A5 JP1997526979A JP52697997A JP2000504328A5 JP 2000504328 A5 JP2000504328 A5 JP 2000504328A5 JP 1997526979 A JP1997526979 A JP 1997526979A JP 52697997 A JP52697997 A JP 52697997A JP 2000504328 A5 JP2000504328 A5 JP 2000504328A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997526979A
Other languages
English (en)
Other versions
JP4063879B2 (ja
JP2000504328A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/001041 external-priority patent/WO1997026784A1/en
Publication of JP2000504328A publication Critical patent/JP2000504328A/ja
Publication of JP2000504328A5 publication Critical patent/JP2000504328A5/ja
Application granted granted Critical
Publication of JP4063879B2 publication Critical patent/JP4063879B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

Figure 2000504328
Figure 2000504328
Figure 2000504328
Figure 2000504328
JP52697997A 1996-01-24 1997-01-23 所望の決定基に対する免疫応答の誘導 Expired - Lifetime JP4063879B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1051096P 1996-01-24 1996-01-24
US60/010,510 1996-01-24
PCT/US1997/001041 WO1997026784A1 (en) 1996-01-24 1997-01-23 Induction of immune response against desired determinants

Publications (3)

Publication Number Publication Date
JP2000504328A JP2000504328A (ja) 2000-04-11
JP2000504328A5 true JP2000504328A5 (ja) 2004-11-11
JP4063879B2 JP4063879B2 (ja) 2008-03-19

Family

ID=21746084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52697997A Expired - Lifetime JP4063879B2 (ja) 1996-01-24 1997-01-23 所望の決定基に対する免疫応答の誘導

Country Status (12)

Country Link
EP (1) EP0876398B1 (ja)
JP (1) JP4063879B2 (ja)
CN (1) CN1214051A (ja)
AT (1) ATE220687T1 (ja)
AU (1) AU1582797A (ja)
BR (1) BR9710404A (ja)
CA (1) CA2242878C (ja)
DE (1) DE69714011T2 (ja)
DK (1) DK0876398T3 (ja)
ES (1) ES2177927T3 (ja)
PT (1) PT876398E (ja)
WO (1) WO1997026784A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528061B1 (en) * 1997-09-04 2003-03-04 Pasteur Institut Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
EP1903056A3 (en) 2002-12-10 2008-05-07 Idm Pharma, Inc. HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof
WO2004052930A2 (en) * 2002-12-11 2004-06-24 Pharmexa A/S Targeting single epitopes
WO2004094454A2 (en) 2003-04-18 2004-11-04 Idm Pharma, Inc. Hla-a2 tumor associated antigen peptides and compositions
ES2310072B1 (es) 2005-12-23 2009-11-16 Proyecto De Biomedicina Cima, S.L. Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
WO2009025777A1 (en) * 2007-08-17 2009-02-26 University Of Maryland Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
WO2010086294A2 (en) 2009-01-28 2010-08-05 Epimmune Inc. Pan-dr binding polypeptides and uses thereof
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
RU2668560C2 (ru) 2013-03-29 2018-10-02 Сумитомо Дайниппон Фарма Ко., Лтд. Конъюгированная вакцина на основе пептида антигена wt1
WO2014157704A1 (ja) * 2013-03-29 2014-10-02 大日本住友製薬株式会社 Erap1によるトリミング機能をきっかけとしたコンジュゲートワクチン
WO2015017734A1 (en) 2013-07-31 2015-02-05 Board Of Trustees Of The University Of Arkansas Compositions for and methods of treating and preventing cancer targeting tumor associated carbohydrate antigens
JP2017518958A (ja) * 2014-03-19 2017-07-13 マッカイ メディカル ファウンデイション ザ プレスビテリアン チャーチ イン タイワン マッカイ メモリアル ホスピタルMackay Medical Foundation The Presbyterian Church In Taiwan Mackay Memorial Hospital 免疫原性グリコペプチドに対する抗体、それを含む組成物、及びそれらの使用
CN107141355B (zh) * 2017-05-31 2021-05-14 中国人民解放军第四军医大学 一种htnv抗原表位线性串联多肽及表位肽-复合物四聚体和应用
CN109991422A (zh) * 2017-12-29 2019-07-09 复旦大学 基于特异抗血清的棕榈酰化修饰蛋白质的检测方法
WO2021228853A1 (en) 2020-05-11 2021-11-18 Ose Immunotherapeutics Vaccine against sars-cov virus
KR102261457B1 (ko) * 2020-07-22 2021-06-09 (주)쓰리에이치바이오 면역 치료제용 펩타이드
BR112023000620A2 (pt) 2020-07-22 2023-03-28 3H Bio Co Ltd Peptídeo usado para imunoterapêuticos
WO2022268916A2 (en) 2021-06-23 2022-12-29 Ose Immunotherapeutics Pan-coronavirus peptide vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960700739A (ko) * 1993-03-05 1996-02-24 카린 이스텀 Hla-a2. 1 결합 펩티드 및 그의 용도(hla-a2. 1 binding peptides and their uses)
CN1135181A (zh) * 1993-09-14 1996-11-06 Cytel有限公司 使用泛dr结合肽改变免疫应答

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2000501771A5 (ja)
JP2000501599A5 (ja)
JP2000501018A5 (ja)
JP2000501324A5 (ja)
JP2000503303A5 (ja)
JP2000502472A5 (ja)
JP2000501338A5 (ja)
JP2000501825A5 (ja)
JP2000500874A5 (ja)
JP2000509515A5 (ja)
JP2000508988A5 (ja)
JP2001507069A5 (ja)
JP2000502485A5 (ja)
JP2000505352A5 (ja)
JP2000501774A5 (ja)
JP2000502425A5 (ja)
JP2000502570A5 (ja)
JP2000502931A5 (ja)
JP2000502568A5 (ja)
JP2000500912A5 (ja)
JP2000501876A5 (ja)
JP2000501744A5 (ja)
JP2000502316A5 (ja)
JP2000500857A5 (ja)